Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chilosi (Verona, Italy). IPF: a morphological and biological entity. Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis

Member's Comments

No comment yet.

Related content which might interest you: IPF: a distinct clinical entity? Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017 IPF: clinical profiles Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis Year: 2010 Clinically important phenotypes of COPD Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 IPF and lung cancer: what are the links? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Clinically important phenotypes of asthma Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 Alveolar NO and alveolar inflammation: biological links and clinical implications Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease Year: 2010 The current classification of the idiopathic interstitial pneumonias: has it advanced pathogenetic understanding Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 IPF or NSIP? That is the question Source: Eur Respir J 2003; 22: 191-192 Year: 2003 Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Gene-set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms Year: 2010 Similarities and links between IPF and cancer: biologic considerations Source: Research Seminar 2015 Year: 2015 The role of pathophysiological aspects and inflammatory markers in phenotyping COPD Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 The role of biomarker profiles in cystic fibrosis Source: Annual Congress 2011 - Exhaled biomarker profiles in paediatric respiratory disease: from bench to bedside? Year: 2011 What is a phenotype and how to define clinical phenotypes of obstructive airway disease Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 COPD: the link between gene-expression and the clinic Source: Annual Congress 2010 - Phenotypic fingerprinting in asthma and COPD: systems biology is entering the clinic Year: 2010 How to define clinically relevant phenotypes and endotypes of asthma and COPD Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 The pathogenesis of IPF: what is the latest paradigm? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019 Pirfenidone dose-response in patients with idiopathic pulmonary fibrosis (IPF): A comprehensive analysis of outcomes in CAPACITY 2 Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010